NCT07164027View on ClinicalTrials.gov

Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 28, 2025

Primary Completion Date

September 28, 2035

Study Completion Date

September 28, 2036

Conditions
Prostate Carcinoma
Interventions
PROCEDURE

Biopsy of Prostate

Undergo biopsy

PROCEDURE

Biospecimen Collection

Undergo collection of blood samples

PROCEDURE

Computed Tomography

Undergo PET/CT

RADIATION

Flotufolastat F-18 Gallium

Given IV

PROCEDURE

Positron Emission Tomography

Undergo PET/CT

Trial Locations (1)

90095

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
collaborator

BLUE EARTH DIAGNOSTICS (UNITED KINGDOM)

UNKNOWN

lead

Jonsson Comprehensive Cancer Center

OTHER